GFG Capital’s Labcorp LH Stock Holding History

GFG Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-45	Closed	-$11.8K	–	214
2025 Q2	$11.8K	Buy	+45	New	+$11K	﹤0.01%	197

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

GFG Capital's LH Position: Q3 2025 in Review

GFG Capital sold out of Labcorp (LH) in Q3 2025, closing a stake of 45 shares — an estimated $11.8K sold.

GFG Capital first reported a position in LH in Q2 2025 and held it in 1 quarter. The position peaked at $11.8K in Q2 2025. 1,012 funds tracked by Wall St. Rank hold LH as of Q3 2025.

GFG Capital reported no remaining Labcorp position as of Q3 2025 after selling out during the quarter.
GFG Capital sold 45 Labcorp shares in Q3 2025, an estimated $11.8K.
GFG Capital first reported a position in Labcorp in Q2 2025 and held it in 1 quarter.
GFG Capital's Labcorp position peaked at $11.8K in Q2 2025.
1,012 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on GFG Capital's 13F filing for Q3 2025, filed 7 Oct 2025.